Navigation Links
Prognostic markers for prostate cancer patients who receive radiation after surgery

SAN DIEGO, CA (November 3, 2010)Removal of the prostate gland often eradicates early-stage cancer. But patients whose cancer has spread may need to follow up with what is known as salvage radiation therapy. Researchers at Fox Chase have now determined a better way to monitor outcomes after this procedure.

A team led by Mark Buyyounouski, M.D., M.S., radiation oncologist at Fox Chase who will present the results at the annual meeting of the American Society for Radiation Oncology, found that levels of a prostate-specific protein up to 18 months after salvage radiation therapy predict mortality and progression of the disease.

"It's important because if you can identify people who are more likely to die of prostate cancer early, you can talk with them about doing another treatment very quickly, with the hope that it will prolong their lives," says Buyyounouski.

Prostate cancer, the most common cancer in men and the second leading cause of cancer deaths in men, causes nearly 220,000 new cases and more than 30,000 deaths each year. The presence of the disease is indicated by the amount of a protein called prostate-specific antigen (PSA). For men who do not undergo surgery, reaching a PSA level of 2 ng/mL within 18 months after radiation treatment is associated with spread of the disease and higher mortality rates. Buyyounouski and his team were curious about whether the same criterion is important for patients who receive radiation after surgery.

In the study, the scientists looked at 222 patients who went through salvage radiation therapy at Fox Chase between 1991 and 2007. They found that roughly half of the men who surpassed threshold PSA levels in the bloodstream within 18 months after treatment experienced spread of the disease or died within five years. By contrast, men whose PSA levels did not reach the threshold within 18 months did not die within five years, and the likelihood that the disease metastasized was only 17% during that time period. The more quickly the PSA rises, the greater the likelihood the disease will attack other organs and cause death.

"These results provide us with an opportunity to identify patients who should be treated aggressively, before we see any other evidence of prostate cancer," Buyyounouski says. On the other hand, men who approach a PSA level of 2 ng/mL 18 months after treatment or later may not require immediate hormonal therapy, he adds. To confirm the findings, Buyyounouski and his team will next extend the investigation to multiple institutions and a larger set of patients.


Contact: Diana Quattrone
Fox Chase Cancer Center

Related medicine news :

1. A prognostic and predictive biomarker for nonsmall cell lung cancer
2. "IPGDx, LLC Announces The Continued Validation Of Its Patented Technology For The Assessment Of Prognosis; PrognostiCheck" Getting the New Information to Patients and Do
3. Radiation pharmacogenomics identifies biomarkers that could personalize cancer treatment
4. Mayo researchers find biomarkers for personalizing radiation cancer treatment
5. Biomarkers May Aid in Early Diagnosis of Alzheimers
6. NIH launches effort to define markers of human immune responses
7. Biomarkers Could Spot Alzheimers Disease Early, Studies Suggest
8. Hydrophobic proteins: Potential biomarkers for colorectal cancer
9. Genetic markers could predict prostate cancer in younger men, U-M study finds
10. UAB researchers find 4 biomarkers important in colorectal cancer treatment prognosis
11. BATTLE links potential biomarkers to drugs for lung cancer
Post Your Comments:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Dr. John ... to learn more about hair loss treatment with the Capillus272™ Pro laser therapy cap. ... solution for thicker and fuller hair, without the need for surgery, prescription pills, or ...
(Date:11/25/2015)... TX (PRWEB) , ... November 25, 2015 , ... For ... the companies’ “ Two Organizations, One Beat ” campaign. The partnership between the two ... services to aid in MAP International’s cause. , MAP International was founded in 1954 ...
(Date:11/25/2015)... ... 25, 2015 , ... Dental professionals who would like to become more proficient ... attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held ... the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud ...
(Date:11/25/2015)... , ... November 25, 2015 , ... The McHenry County ... recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. ... Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Care Market by Type (Dressings, Therapy Devices, Active Wound ... Out-Patient Facility), and Geography - Global Forecast to 2020" ... --> --> The purpose of this ... of the global advanced wound care market. It involves ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)... 2015  The American Academy of Pediatrics (AAP), ... the March of Dimes cheered today,s signature into ... Act of 2015 (S.799), which takes much-needed ... exposed to drugs, such as opioids, and to ... three organizations have worked together leading advocacy efforts ...
Breaking Medicine Technology: